Bioorg Med Chem Lett
July 2017
A series of (Z)-4-(3-carbamoylphenylamino)-4-oxobut-2-enyl amides were synthesized and tested for their ability to inhibit the mono-(ADP-ribosyl)transferase, PARP14 (a.k.a.
© LitMetric 2025. All rights reserved.